Acebutolol hydrochloride

Acebutolol hydrochloride is the hydrochloride salt of acebutolol, prepared using equimolar amounts of acebutolol and hydrogen chloride. Among its listed roles, it functions as a anti-arrhythmia drug, a beta-adrenergic antagonist, an antihypertensive agent and a sympathomimetic agent. It includes a acebutolol(1+). Acebutolol hydrochloride is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated in hypertension and ventricular arrhythmia. It is grouped under the following drug class(es): Antianginals and Beta blockers. Its therapeutic use is listed as angina, antihypertensives and cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Diasectral, Wesfalin, Prent, Neptal and Acetanol. Its PubChem CID is 441307.